Eosinophilic esophagitis is an emerging disease that is distinguished from
gastroesophageal reflux disease by the expression of a unique esophageal transcriptome …

Early in the 1990s, several case series described adults suffering from dysphagia and
children with refractory reflux symptoms, both accompanied by an eosinophil‐predominant …

Background Phenotypes of eosinophilic esophagitis (EoE) are not well-characterized.
Objective To describe clinical features of patients with EoE with predefined phenotypes …

Background & Aims Pharmacologic treatment of eosinophilic esophagitis (EoE) is limited to
off-label use of corticosteroids not optimized for esophageal delivery. We performed a …

Abstract The Joint Task Force for the American Academy of Allergy Asthma Immunology and
American College of Allergy Asthma Immunology and the American Gastroenterology …

Summary Background Proton pump inhibitors (PPIs) are the most commonly used first‐line
therapy for patients with eosinophilic oesophagitis (EoE). However, many aspects related to …

Eosinophilic esophagitis (EoE) is a chronic immune antigen-mediated disease (Box 1). 1–3
Patients who have EoE respond to antigen elimination, especially elimination of food …

In the absence of secondary causes, eosinophilic esophagitis (EoE) is a chronic, local,
progressive, T-helper type 2 immune-mediated disorder characterized by symptoms of …

Eosinophilic esophagitis (EoE) is a chronic immune-mediated disease of the esophagus
characterized clinically by symptoms related to esophageal dysfunction and histologically by …

Eosinophilic esophagitis (EoE) is a chronic inflammatory disease characterized by
eosinophilic infiltration of the esophagus. It arises from a complex interplay of genetic …